Evropska unija - slovenščina - EMA (European Medicines Agency)

ucb pharma s.a. - lakosamid - epilepsije, delno - antiepileptics, - lacosamide ucb je označen kot monotherapy in adjunctive terapija pri zdravljenju delno-nastop napadi z ali brez sekundarne posplošitev pri odraslih, mladostnikih in otrocih od 4 let z epilepsijo.

Evropska unija - slovenščina - EMA (European Medicines Agency)

extrovis eu ltd. - lakosamid - epilepsija - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

accord healthcare s.l.u. - lakosamid - epilepsija - antiepileptics, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

accord healthcare - lakozamid - filmsko obložena tableta - lakozamid 200 mg / 1 tableta - lakozamid

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

accord healthcare - lakozamid - filmsko obložena tableta - lakozamid 50 mg / 1 tableta - lakozamid

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

accord healthcare - lakozamid - filmsko obložena tableta - lakozamid 150 mg / 1 tableta - lakozamid

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

accord healthcare - lakozamid - filmsko obložena tableta - lakozamid 100 mg / 1 tableta - lakozamid

Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international nv - etravirine - okužbe z virusom hiv - non-nucleoside reverse transcriptase inhibitors, antivirals for systemic use - intelence, v kombinaciji z inhibitor proteaz povečala in drugih protiretrovirusna zdravila, je indicirano za zdravljenje okužbe ljudi-imunske pomanjkljivosti-virus-tipa 1 (hiv-1) v doživeli protiretrovirusno zdravljenje odraslih bolnikov in v protiretrovirusno zdravljenje, izkušeni pediatrični bolniki iz šestih let. ta navedba temelji na teden-48 analize iz dveh faza-iii preskušanj v zelo pretreated bolnikih, kjer intelence je v preiskavi v kombinaciji z optimalnim ozadju režim (obr), ki je vključevala darunavir/ritonavir. navedba v pediatričnih bolnikih, ki temelji na 48-tedensko analiz eno roko, faza ii sojenja v protiretrovirusno zdravljenje z izkušenimi pediatričnih bolnikih.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

genthon bv - bikalutamid - filmsko obložena tableta - bikalutamid 150 mg / 1 tableta - bikalutamid

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

dechra regulatory -